Literature DB >> 11087733

3-phosphoinositide-dependent protein kinase 1, an Akt1 kinase, is involved in dephosphorylation of Thr-308 of Akt1 in Chinese hamster ovary cells.

T Yamada1, H Katagiri, T Asano, K Inukai, M Tsuru, T Kodama, M Kikuchi, Y Oka.   

Abstract

To investigate the role of 3-phosphoinositide-dependent protein kinase 1 (PDK1) in the Akt1 phosphorylation state, wild-type (wt) PDK1 and its kinase dead (kd) mutant were expressed using an adenovirus gene transduction system in Chinese hamster ovary cells stably expressing insulin receptor. Immunoblotting using anti-phosphorylated Akt1 antibody revealed Thr-308 already to be maximally phosphorylated at 1 min but completely dephosphorylated at 5 min, with insulin stimulation, whereas insulin-induced Akt1 activation was maintained even after dephosphorylation of Thr-308. Overexpression of wt-PDK1 further increased insulin-stimulated phosphorylation of Thr-308, also followed by rapid dephosphorylation. The insulin-stimulated Akt1 activity was also enhanced by wt-PDK1 expression but was maintained even at 15 min. Thus, phosphorylation of Thr-308 is not essential for maintaining the Akt1 activity once it has been achieved. Interestingly, the insulin-stimulated phosphorylation state of Thr-308 was maintained even at 15 min in cells expressing kd-PDK1, suggesting that kd-PDK1 has a dominant negative effect on dephosphorylation of Thr-308 of Akt1. Calyculin A, an inhibitor of PP1 and PP2A, also prolonged the insulin-stimulated phosphorylation state of Thr-308. In addition, in vitro experiments revealed PP2A, but not PP1, to dephosphorylate completely Thr-308 of Akt1. These findings suggest that a novel pathway involving dephosphorylation of Akt1 at Thr-308 by a phosphatase, possibly PP2A, originally, identified as is regulated downstream from PDK1, an Akt1 kinase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087733     DOI: 10.1074/jbc.M005685200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Quantitative analysis of Akt phosphorylation and activity in response to EGF and insulin treatment.

Authors:  Neil Kumar; Raffi Afeyan; Sarah Sheppard; Brian Harms; Douglas A Lauffenburger
Journal:  Biochem Biophys Res Commun       Date:  2007-01-02       Impact factor: 3.575

2.  Loss of PI(4,5)P2 5-Phosphatase A Contributes to Resistance of Human Melanoma Cells to RAF/MEK Inhibitors.

Authors:  Yan Ye; Qun Li; Wang Lai Hu; Hsin-Yi Tseng; Lei Jin; Xu Dong Zhang; Lin Jie Zhang; Sen Yang
Journal:  Transl Oncol       Date:  2013-08-01       Impact factor: 4.243

3.  Tumour necrosis factor-alpha activation of protein kinase B in WEHI-164 cells is accompanied by increased phosphorylation of Ser473, but not Thr308.

Authors:  A O'toole; S K Moule; P J Lockyer; A P Halestrap
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

4.  Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development.

Authors:  Ryan F L O'Shaughnessy; Jonathan C Welti; Katherine Sully; Carolyn Byrne
Journal:  Development       Date:  2009-09-17       Impact factor: 6.868

5.  Activation of Notch-mediated protective signaling in the myocardium.

Authors:  Natalie A Gude; Gregory Emmanuel; Weitao Wu; Christopher T Cottage; Kimberlee Fischer; Pearl Quijada; John A Muraski; Roberto Alvarez; Marta Rubio; Eric Schaefer; Mark A Sussman
Journal:  Circ Res       Date:  2008-03-27       Impact factor: 17.367

6.  Analysis of 3-phosphoinositide-dependent kinase-1 signaling and function in ES cells.

Authors:  Tanja Tamgüney; Chao Zhang; Dorothea Fiedler; Kevan Shokat; David Stokoe
Journal:  Exp Cell Res       Date:  2008-04-23       Impact factor: 3.905

7.  Mechanism of activation of PKB/Akt by the protein phosphatase inhibitor Calyculin A.

Authors:  Mercedes Pozuelo-Rubio; Nick R Leslie; Jane Murphy; Carol Mackintosh
Journal:  Cell Biochem Biophys       Date:  2010-12       Impact factor: 2.194

8.  CSTP1, a novel protein phosphatase, blocks cell cycle, promotes cell apoptosis, and suppresses tumor growth of bladder cancer by directly dephosphorylating Akt at Ser473 site.

Authors:  De-Xiang Zhuo; Xiao-Wei Zhang; Bo Jin; Zheng Zhang; Bu-Shan Xie; Cheng-Lin Wu; Kan Gong; Ze-Bin Mao
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

9.  PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma.

Authors:  Yan Ye; Lei Jin; James S Wilmott; Wang Lai Hu; Benafsha Yosufi; Rick F Thorne; Tao Liu; Helen Rizos; Xu Guang Yan; Li Dong; Kwang Hong Tay; Hsin-Yi Tseng; Su Tang Guo; Charles E de Bock; Chen Chen Jiang; Chun Yan Wang; Mian Wu; Lin Jie Zhang; Peter Hersey; Richard A Scolyer; Xu Dong Zhang
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.